NCT05168995View on ClinicalTrials.gov

Effects of Beclometasone Dipropionate/Formoterol Fumarate Via NEXT(Haler) in a Real-world Study on Asthma Control

CompletedOBSERVATIONAL

Enrollment

620

Participants

Timeline

Start Date

April 12, 2022

Primary Completion Date

February 9, 2024

Study Completion Date

February 9, 2024

Conditions

Asthma

Interventions

DRUG

BDP/FF NEXThaler® 100/6 micrograms

"BDP/FF NEXThaler® 100/6 maintenance treatment: one or two inhalations twice daily (one inhalation in the morning and one inhalation in the evening).~BDP/FF NEXThaler® 100/6 maintenance and reliever treatment (MART)"

Trial Locations (1)

Unknown

Ospedale dell'Angelo, Mestre

All Listed Sponsors

lead

Chiesi Italia

INDUSTRY